Contact this trialFirst, we need to learn more about you.
Antisense Oligonucleotide
Antisense Oligonucleotide Treatment for Retinitis Pigmentosa
Recruiting1 awardPhase < 1
Aurora, Colorado
This trial aims to test a new medication in one patient with a specific type of ataxia and retinitis pigmentosa. The main focus is on determining how safe and well-tolerated the
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service